These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 174288)

  • 21. Synthesis of Epstein-Barr virus antigens and DNA in activated Burkitt somatic cell hybrids.
    Glaser R; Nonoyama M; Decker B; Rapp F
    Virology; 1973 Sep; 55(1):62-9. PubMed ID: 4353957
    [No Abstract]   [Full Text] [Related]  

  • 22. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superinfection epithelial nasopharyngeal carcinoma cells with Epstein-Barr virus.
    Glaser R; de Thé G; Lenoir G; Ho JH
    Proc Natl Acad Sci U S A; 1976 Mar; 73(3):960-3. PubMed ID: 176664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dibutyryl cyclic AMP on the induction of Epstein-Barr virus in hybrid cells.
    Zimmerman JE; Glaser R; Rapp F
    J Virol; 1973 Dec; 12(6):1442-5. PubMed ID: 4357515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription of latent Epstein--Barr virus genomes in human epithelial/Burkitt hybrid cells.
    Tanaka A; Nonoyama M; Glaser R
    Virology; 1977 Oct; 82(1):63-8. PubMed ID: 197704
    [No Abstract]   [Full Text] [Related]  

  • 26. Virus-induced antigens - a review.
    Klein G
    IARC Sci Publ (1971); 1975; (11 Pt 1):293-308. PubMed ID: 190131
    [No Abstract]   [Full Text] [Related]  

  • 27. [Epstein-Barr virus and human cells: transforming and cell-killing infections (author's transl)].
    Mizuno F
    Hokkaido Igaku Zasshi; 1978 Nov; 53(6):489-95. PubMed ID: 230999
    [No Abstract]   [Full Text] [Related]  

  • 28. Somatic cell hybrids between human lymphoma and human myeloid leukemia cells. I. Induction of resident viral genome transcription and viral antigen formation by IUDR and TPA.
    Lau RY; Nonoyama M; Klein G
    Virology; 1981 Apr; 110(2):259-69. PubMed ID: 6261446
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of chemical Epstein-Barr virus induction by dimethyl sulfoxide and related polar compounds.
    Yanase S; Sugawara K
    Intervirology; 1989; 30(3):163-8. PubMed ID: 2546900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of Epstein-Barr virus antigens in human lymphoblastoid P3HR-1 cells with culture fluid of Fusobacterium nucleatum.
    Ito Y; Kishishita M; Yanase S
    Cancer Res; 1980 Nov; 40(11):4329-30. PubMed ID: 6258779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time of synthesis and cellular location of Epstein-Barr virus-specified polypeptides radioimmunoprecipitated from iododeoxyuridine-induced Burkitt lymphoma/somatic cell hybrids.
    Durnford JM; Scanlon PA; Glaser R
    J Gen Virol; 1982 May; 60(Pt 1):39-48. PubMed ID: 6284867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus latency and bacteriophage P1 lysogeny-possible analogies.
    Adams A
    Bibl Haematol; 1975 Oct; (43):297-301. PubMed ID: 183687
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunofluorescent antigen associated with Epstein-Barr virus induced by 5-Iododeoxyuridine.
    Sugawara K; Osato T
    Nat New Biol; 1973 Nov; 246(151):72-3. PubMed ID: 4357309
    [No Abstract]   [Full Text] [Related]  

  • 35. Infection of the human T-cell-derived leukemia line Molt-4 by Epstein-Barr virus (EBV): induction of EBV-determined antigens and virus reproduction.
    Shapiro IM; Volsky DJ; Saemundsen AK; Anisimova E; Klein G
    Virology; 1982 Jul; 120(1):171-81. PubMed ID: 6285596
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine.
    Souyri-Caporale M; Tovey MG; Ono K; Jasmin C; Chermann JC
    J Gen Virol; 1984 Apr; 65 ( Pt 4)():831-5. PubMed ID: 6323625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of Epstein-Barr virus in hybrid cells.
    Tsang KY; Hann WD
    J Natl Cancer Inst; 1977 May; 58(5):1295-301. PubMed ID: 192898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle.
    Klein G; Clements G; Zeuthen J; Westman A
    Int J Cancer; 1976 Jun; 17(6):715-24. PubMed ID: 59708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of protease inhibitors on the activation of Epstein-Barr virus repressed in cultured lymphoid cells.
    Morigaki T; Sugawara K; Ito Y
    Intervirology; 1981; 16(1):49-52. PubMed ID: 6276326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.